Perrigo Company plc (PRGO)

NYSE · Drug Manufacturers - Specialty & Generic

15.96
-0.41 (-2.50%)
Updated Oct 23, 11:14 PM ET
AI Rating
Strong Buy
Overall Score
80
Trend
100
Momentum
78
Risk
52

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Oct 6, 2025 260 sessions Oct 16, 2026

AI Analysis

Perrigo Company plc is trading at $16.37, up 2.89% on the session. The 50 day average sits at $14.23 and the 200 day at $12.37, which puts the stock in a uptrend. RSI is at 70.6, which reads as overbought, and MACD is bullish crossover. Volume is below average.

The nearest support is around $14.00 with resistance near $16.68, so that band frames the current range. Average daily movement is roughly $0.68, or about 4.1% of the share price, which is what any stop placement has to allow for. The overall health score of 80 out of 100 combines a trend score of 100, momentum of 78 and a risk score of 52.

Technical indicators

RSI (14)
70.6
overbought
MACD
0.587
bullish crossover
SMA 20
14.90
SMA 50
14.23
SMA 200
12.37
uptrend
ATR (14)
0.68
avg daily range
Support
14.00
Resistance
16.68
Volume vs 20d
0.79x
below average
Volatility
48.5%
annualised
1 month
+23.37%
3 months
+57.04%

AI trade signals on PRGO

All signals
Date Setup Entry Target Stop R:R Status
Sep 29 Momentum ••.•• ••.•• ••.•• 9.76:1 Expired

About Perrigo Company plc

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.